Novo Nordisk A/S (CPH:NOVO.B)
263.20
-1.95 (-0.74%)
Nov 20, 2026, 12:06 PM CET
Novo Nordisk Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Hold" and an average price target of krĀ 299.91. The average 1-year stock price forecast is 13.95% higher than the current stock price, while the lowest is krĀ 221.00 (-16.03%) and the highest is krĀ 448.00 (+70.21%).
Price Target: krĀ 299.91 (+13.95%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 17 | 18 | 17 | 16 | 15 | 15 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 2 | 3 | 5 | 5 |
| Total | 26 | 26 | 25 | 25 | 26 | 26 |
Financial Forecast
Revenue This Year
310.52B
from 309.06B
Increased by 0.47%
Revenue Next Year
313.51B
from 310.52B
Increased by 0.96%
EPS This Year
22.79
from 23.03
Decreased by -1.04%
EPS Next Year
22.57
from 22.79
Decreased by -0.98%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.